(S) -DOTAGA. (SA.FAPi) 2

(S) -DOTAGA. (SA.FAPi) 2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs) . RDCs have the capability to specifically target biomolecules and can be used in medical imaging[1].

Product Specifications

CAS Number

[2417089-06-4]

UNSPSC

12352203

Target

Radionuclide-Drug Conjugates (RDCs)

Type

Reference compound

Related Pathways

Antibody-drug Conjugate/ADC Related

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/s-dotaga-sa-fapi-2.html

Smiles

N#C[C@@H]1CC(F)(CN1C(CNC(C2=CC=NC3=C2C=C(C=C3)OCCCCNC4=C(C(C4=O)=O)NCCNC(CC[C@H](N5CCN(CCN(CCN(CC5)CC(O)=O)CCNC6=C(C(C6=O)=O)NCCCCOC7=CC8=C(N=CC=C8C(NCC(N9CC(F)(C[C@H]9C#N)F)=O)=O)C=C7)CC(O)=O)C(O)=O)=O)=O)=O)F